MASI
Masimo Corporation
Is MASI Halal?
Medical-monitoring technology with a consumer-audio segment — generally permissible activity whose known current asset-based ratios pass, with activity classification incomplete.
What You Should Know
Masimo's April 4, 2026 Form 10-Q reports assets of $1,642.7 million, debt of $452.0 million, cash of $124.6 million, receivables of $248.7 million and quarterly revenue of $403.6 million. Debt/assets is 27.51%, liquidity/assets is 7.59%, receivables plus cash/assets is 22.69% and disclosed interest income is 0.22% of revenue. Known ratios pass, but no universal prohibited-revenue numerator is disclosed.
⚠️ Concerns
- •Known asset-based ratios pass, but no universal prohibited-revenue numerator is disclosed
- •Consumer-audio segment and strategic alternatives
- •Medical-device regulatory and product-liability exposure
- •Acquisition-related debt and mixed product end uses
- •Disclosed interest income is 0.22% of quarterly revenue; no fixed purification percentage asserted
Current quantitative Sharia screen
Based on 10-Q figures for the period ended 2026-04-04; calculated 2026-07-15.
452 / 1,642.7
124.6 / 1,642.7
373.3 / 1,642.7
0.9 / 403.6
- Financial
- Pass
- Overall
- Incomplete
Debt/assets is 27.51%, liquidity/assets is 7.59%, receivables-plus-cash/assets is 22.69% and interest income is 0.22%; activity remains incomplete.
- Financial
- Pass
- Overall
- Incomplete
Known financial ratios pass; this is not an index-membership claim and activity remains incomplete.
- Financial
- Pass
- Overall
- Incomplete
Known debt, liquidity and income ratios pass; this is not an official classification.
- Financial
- Not calculated
- Overall
- Incomplete
A licensed historical market-cap series is not stored.
Business-activity disclosure
Masimo develops patient-monitoring and medical technologies, with a consumer-audio and health segment. Medical-device activity is generally permissible, but the filing does not provide a universal prohibited-revenue numerator for the mixed product portfolio.
Limitation: No universal prohibited-activity revenue numerator or scholar-specific purification percentage is disclosed.
Purification
Interest income is disclosed, but no scholar-approved purification percentage or universal activity allocation is calculated.
Inputs, assumptions and primary sources
- Amounts are USD millions from Masimo's April 4, 2026 Form 10-Q.
- Debt is current and non-current long-term debt of $6.3 million and $445.7 million; operating leases are excluded.
- Cash is $124.6 million. Accounts receivable uses $228.0 million trade receivables plus $10.7 million related-party receivables.
- Quarterly revenue is $403.6 million and disclosed interest income is $0.9 million (0.22% of revenue).
- Medical monitoring and consumer-audio activities remain qualitative; no universal prohibited-revenue numerator is disclosed.
This is a reproducible financial screen, not a fatwa. A failed total-assets screen can coexist with a pass under a market-cap methodology. ZakatInvest keeps the qualitative assessment separate so numerical thresholds do not erase material context.
Similar Stocks
Want to screen more assets?
Use our interactive Halal Checker to screen any stock, ETF, or crypto instantly.
Go to Halal Checker →